The Cardiopulmonary Bypass System Market is anticipated to reach US$ 271 million in value by 2032, up from US$ 192 million in 2022, growing at a CAGR of 3.2% over the forecast period. Cardiopulmonary ...

Cardiopulmonary bypass system is medical device that takes over the function of heart and lungs for temporary basis during the cardiac surgery. Cardiopulmonary bypass system helps in maintaining the ...

Abiomed announced that the United States Food and Drug Administration (FDA) have granted a 510(k) clearance for an all-in-one, compact cardiopulmonary bypass system called the Abiomed Breethe OXY-1 ...

DANVERS, Mass.--(BUSINESS WIRE)--The United States Food and Drug Administration (FDA) has granted Abiomed (NASDAQ: ABMD) a 510(k) clearance for an all-in-one, compact cardiopulmonary bypass system ...

Alterations in the hematologic system, immobility, and venous stasis place the critically ill obese patient at increased risk of thrombus formation. Because increased adipose tissue may mask swelling ...

New York, June 23, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cardiopulmonary Stress Testing System Market Research Report by Product, by Application, by End User - ...

This briefing describes the regulated use of the technology for the indication specified, in the setting described, and with any other specific equipment referred to. It is the responsibility of ...